Published 3 days ago • loading... • Updated 3 days ago

TreeFrog Raises €30 Million in Quasi-Equity to Fund Its Regenerative Medicine Trials

Summary by FrenchWeb.fr

The Bordeaux biotech TreeFrog Therapeutics is taking a strategic step by obtaining funding of €30 million from the European Investment Bank (EIB). Particularity of this operation, the use of quasi-equity, a hybrid mechanism still rare in the world of biotechnology.This support will allow the company to launch its first human clinical trials ... L-article TreeFrog raises €30 million in quasi-equity to finance its regenerative medicine trials firs…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All

Left

Center

Right

FrenchWeb.fr

TreeFrog Raises €30 Million in Quasi-Equity to Fund Its Regenerative Medicine Trials

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated3 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

FrenchWeb.fr broke the news in 3 days ago on Wednesday, May 28, 2025.

Sources are mostly out of (0)

TreeFrog Raises €30 Million in Quasi-Equity to Fund Its Regenerative Medicine Trials

1 Articles

1 Articles

TreeFrog Raises €30 Million in Quasi-Equity to Fund Its Regenerative Medicine Trials

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics